Global footprint SSI has installed over 2,000 ultrasound systems in more than 80 countries, with main growth markets in China, the U.S. and the EU. This suggests strong international demand and opportunities to upsell or cross-sell upgraded UltraFast technology–driven solutions to existing customers and expand into high-potential regions.

Advanced tech The UltraFast technology and ShearWave Elastography are core differentiators with substantial clinical validation (over 600 published articles). This positions SSI to target imaging centers focusing on breast, liver, and prostate diagnostics, offering premium modalities and potential service contracts around maintenance of sophisticated platforms.

Regulatory readiness With CE certification and FDA cleared status for Aixplorer MACH 30, SSI demonstrates compliance across major markets. This reliability supports outreach to hospitals and clinics seeking compliant, state-of-the-art ultrasound systems, including facilities upgrading instrumentation for regulatory or accreditation needs.

Market momentum Historical product launches and expansions, including Aixplorer MACH 30 enhancements and premium Aixplorer Ultimate, indicate a trajectory of continuous innovation. Sales opportunities exist in multi-system deals, training partnerships, and trade-ins from institutions adopting newer models.

Strategic partnerships Past events show corporate interest from potential acquirers and collaborators, suggesting avenues for channel partnerships, distribution agreements, and joint ventures to accelerate market penetration, especially in key regions and large healthcare networks.